|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/10 | (2006.01) |
| C07D 401/10 | (2013.01) | ||
| A61K 31/404 | (2006.01) | ||
| C07D 403/10 | (2013.01) | ||
| A61K 31/4155 | (2006.01) | ||
| C07D 209/34 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/404 | (2013.01) | ||
| C07D 403/10 | (2006.01) | ||
| A61K 31/4155 | (2013.01) | ||
| C07D 209/34 | (2006.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 209/38 | (2013.01) | ||
| C07D 401/06 | (2013.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/00 | (2018.01) |
| (11) | Patento numeris | 3204376 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15784237.8 |
| Europos patento paraiškos padavimo data | 2015-10-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-04-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/054533 |
| Data | 2015-10-07 |
| (87) | Numeris | WO 2016/057698 |
| Data | 2016-04-14 |
| (30) | Numeris | Data | Šalis |
| 201462062086 P | 2014-10-09 | US |
| (72) |
VERNIER, Jean-Michel , US
|
| (73) |
Oncternal Therapeutics, Inc. ,
3525 Del Mar Heights Road, 821, San Diego CA 92130,
US
|
| (54) | INDOLINONE COMPOUNDS AND USES THEREOF |
| INDOLINONE COMPOUNDS AND USES THEREOF |